Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014 (2014), Article ID 579560, 3 pages
http://dx.doi.org/10.1155/2014/579560
Editorial

Immune and Inflammatory Processes in Obesity, Insulin Resistance, Diabetes, and Related Cardiometabolic Complications

1Department of Physiology, University of Saskatchewan College of Medicine, 107 Wiggins Road, Saskatoon, SK, Canada S7N 5E5
2Division of Cardiovascular Medicine, Department of Medicine, Henry Ford Heart & Vascular Institute, 2799 West Grand Boulevard, Detroit, MI 48202-2689, USA
3Department of Pharmacology, Center for Integrative Medicine, Center for Molecular Medicine (CIMMBA), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy

Received 15 September 2014; Accepted 15 September 2014; Published 21 September 2014

Copyright © 2014 Joseph Fomusi Ndisang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Hossain, B. Kawar, and M. El Nahas, “Obesity and diabetes in the developing world—a growing challenge,” The New England Journal of Medicine, vol. 356, no. 3, pp. 213–215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. WHO, “Obesity and overweight,” Fact Sheet 311, World Health Organization, 2006. View at Google Scholar
  3. J. F. Ndisang, “Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity,” Mediators of Inflammation, vol. 2010, Article ID 359732, 18 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Mishra and J. F. Ndisang, “A critical and comprehensive insight on heme oxygenase and related products including carbon monoxide, bilirubin, biliverdin and ferritin in type-1 and type-2 diabetes,” Current Pharmaceutical Design, vol. 20, no. 9, pp. 1370–1391, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Tiwari and J. F. Ndisang, “The heme oxygenase system and type-1 diabetes,” Current Pharmaceutical Design, vol. 20, no. 9, pp. 1328–1337, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. J. F. Ndisang and R. Wang, “Age-related alterations in soluble guanylyl cyclase and cGMP pathway in spontaneously hypertensive rats,” Journal of Hypertension, vol. 21, no. 6, pp. 1117–1124, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. J. F. Ndisang and A. Jadhav, “Upregulating the heme oxygenase system suppresses left ventricular hypertrophy in adult spontaneously hypertensive rats for 3 months,” Journal of Cardiac Failure, vol. 15, no. 7, pp. 616–628, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Jadhav and J. F. Ndisang, “Heme arginate suppresses cardiac lesions and hypertrophy in deoxycorticosterone acetate-salt hypertension,” Experimental Biology and Medicine, vol. 234, no. 7, pp. 764–778, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. F. Ndisang, R. Wang, A. Vannacci et al., “Haeme oxygenase-1 and cardiac anaphylaxis,” British Journal of Pharmacology, vol. 134, no. 8, pp. 1689–1696, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. S. A. Robertson, W. V. Ingman, S. O'Leary, D. J. Sharkey, and K. P. Tremellen, “Transforming growth factor β—a mediator of immune deviation in seminal plasma,” Journal of Reproductive Immunology, vol. 57, no. 1-2, pp. 109–128, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. I.-S. Lean, S. A. C. McDonald, M. Bajaj-Elliott, R. C. G. Pollok, M. J. G. Farthing, and V. McDonald, “Interleukin-4 and transforming growth factor β have opposing regulatory effects on gamma interferon-mediated inhibition of Cryptosporidium parvum reproduction,” Infection and Immunity, vol. 71, no. 8, pp. 4580–4585, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. J. C. K. Leung, L. Y. Y. Chan, A. W. L. Tsang et al., “Anti-macrophage migration inhibitory factor reduces transforming growth factor-β1 expression in experimental IgA nephropathy,” Nephrology Dialysis Transplantation, vol. 19, no. 8, pp. 1976–1985, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Karakaya, C. H. van Moorsel, A. H. van der Helm-van Mil et al., “Macrophage migration inhibitory factor (MIF) -173 polymorphism is associated with clinical erythema nodosum in Lofgren's syndrome,” Cytokine, vol. 69, no. 2, pp. 272–276, 2014. View at Google Scholar
  14. N. Coban, A. Onat, O. Yildirim, G. Can, and N. Erginel-Unaltuna, “Oxidative stress-mediated (sex-specific) loss of protection against type-2 diabetes by macrophage migration inhibitory factor (MIF)-173G/C polymorphism,” Clinica Chimica Acta, vol. 438, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  15. F. Y. McWhorter, T. Wang, P. Nguyen, T. Chung, and W. F. Liu, “Modulation of macrophage phenotype by cell shape,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 43, pp. 17253–17258, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Jadhav, S. Tiwari, P. Lee, and J. F. Ndisang, “The heme oxygenase system selectively enhances the anti-inflammatory macrophage-m2 phenotype, reduces pericardial adiposity, and ameliorated cardiac injury in diabetic cardiomyopathy in zucker diabetic fatty rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 345, no. 2, pp. 239–249, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. B. E. K. Klein, “Overview of epidemiologic studies of diabetic retinopathy,” Ophthalmic Epidemiology, vol. 14, no. 4, pp. 179–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. G. E. Lang, “Diabetic macular edema,” Ophthalmologica, vol. 227, supplement 1, pp. 21–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. K. H. Dyer, P. S. Silva, and J. K. Sun, “Vascular endothelial growth factor gene polymorphisms and vitreous proteome changes in diabetic retinopathy,” Seminars in Ophthalmology, vol. 28, no. 5-6, pp. 347–354, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. D. S. Boyer, J. J. Hopkins, J. Sorof, and J. S. Ehrlich, “Anti-vascular endothelial growth factor therapy for diabetic macular edema,” Therapeutic Advances in Endocrinology and Metabolism, vol. 4, no. 6, pp. 151–169, 2013. View at Publisher · View at Google Scholar · View at Scopus